Loading clinical trials...
Loading clinical trials...
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Interventional Endoscopy Services
San Francisco, California, United States
Start Date
July 1, 2011
Primary Completion Date
December 1, 2030
Completion Date
December 1, 2030
Last Updated
February 11, 2025
4,000
ESTIMATED participants
Lead Sponsor
California Pacific Medical Center Research Institute
NCT06663319
NCT06048146
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions